Promising new developments in cervical cancer. (July 2014)

• Record Type: Journal Article
• Authors: McCormack, Mary
• Is Part Of: Future oncology. Volume 10:Number 9(2014)
• Page Start: 1541
• Page End: 1544
• Publication Date: 2014-07
• Subjects: bevacizumab -- cervical cancer -- INTERLACE -- relapsed disease -- research; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon.14.63
• Languages: English
• ISSNs: 1479-6694

Abstract

Mary McCormack* speaks to Francesca Lake, Managing Commissioning Editor: Dr McCormack qualified as a doctor from Guy's and St Thomas's Hospital (London, UK) in 1993. She has worked in a variety of London cancer centers and was appointed as a consultant at University College London Hospitals (London, UK) in 2002. She is a clinical oncologist, offering chemotherapy and radiotherapy for gynecological and breast cancers. She is a member of the National Cancer Research Institute Gynecological Clinical Studies Group and the Gynecologic Cancer InterGroup, and is a major contributor to national and international clinical trials. She is also a medical advisor to Jo's Trust and a founding member of Debbie Fund, a University College London-based charity dedicated to raising funds for cervical cancer research.